Usted está aquí

Inicio / 1%

Selection of phage-displayed human antibody fragments specific for CD1b presenting theMycobacterium tuberculosis glycolipid Ac2SGL

Isolation of 1E4 IgM Anti-Fasciola hepatica Rediae Monoclonal Antibody from Ascites: Comparison of Two Purification Protocols

Immunological evaluation of rheumatoid arthritis patients treated with itolizumab

Co-Localization of CD133/EGFR and Antiangiogenic Activity Drive the Antitumor Effect of Nimotuzumab and Radiation in Human GBM U87MG Xenografted in Mice.

Safety and effectiveness of nimotuzumab in patients with malignant glial tumors

Immunological evaluation of rheumatoid arthritis patients treated with itolizumab.

Treatment outcome of nimotuzumab plus chemotherapy in advanced cancer patients: a single institute experience

Isolation of 1E4 IgM Anti-Fasciola hepatica Rediae Monoclonal Antibody from Ascites: Comparison of Two Purification Protocols

Treatment outcome of nimotuzumab plus chemotherapy in advanced cancer patients: a single institute experience

Distinctions among Circulating Antibody-Secreting Cell Populations, Including B-1 Cells, in Human Adult Peripheral Blood

Páginas

Pizarra
53-7-2717933
Dirección general
53-7-2714335
cim@cim.sld.cu
Calle 15 esq. 216 S/N, Siboney, Playa, La Habana, Cuba. A.P 16040, La Habana 11600, Cuba.
Código Postal:
11 600
Apartado Postal:
16 040